Marao, Taiba H.

HRN: 132647  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/09/2022
MUPIROCIN 2%, 15G (TUBE)
04/09/2022
04/16/2022
TOPICAL
2%
TID
Infected Bed Sores, DM Type II
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: No  Wrong Dose  Decrease To BID

Final appropriateness: No  Wrong Dose 

Overall appropriateness: No 

Intervention



Type of Intervention done:

                    

           


Acceptance: